We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Mylan Launches Generic Yasmin® Tablets

Product News   Sep 10, 2015

 
Mylan Launches Generic Yasmin® Tablets
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Product News

Regeneron has announced the first data from a descriptive analysis of a Phase 1/2/3 trial of the investigational antibody cocktail known as "REGN-COV2". Results show that it reduced viral load and alleviated symptoms in non-hospitalized patients with COVID-19.

READ MORE

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published

Product News

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE